Literature DB >> 6279496

Aldosterone infusion into the rat and dose-dependent changes in blood pressure and arterial ionic transport.

E T Garwitz, A W Jones.   

Abstract

Induction of hypertension by implantation or injection of deoxycorticosterone acetate (DOCA) requires a dose well above the physiological range. The objective of this study was to produce hypertension in rats by chronic infusion of d-aldosterone, a more potent mineralocorticoid. Aldosterone infused at a dose of 1 microgram/hr for 4 weeks gave maximal rise in systolic blood pressure (132 +/- 3 vs 203 +/- 7 mm Hg). A significant rise in blood pressure was achieved at 0.1 microgram/hr (170 +/- 6 mm Hg) which was associated with a 2.3-fold rise in plasma aldosterone levels (7.6 +/- 0.4 vs 17.7 +/- 2.2 ng/dl). A series of isotope flux studies on the aorta and femoral artery from hypertensive animals demonstrated increases in 42K and 36Cl turnover. In both vessels the largest changes in ion turnover were observed in vessels from animals infused with aldosterone at 0.25 micrograms/hr. Increases in 42K and 36Cl turnover were detected as early as 1 week after the start of aldosterone infusion, well before a significant rise in blood pressure had occurred.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6279496     DOI: 10.1161/01.hyp.4.3.374

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  6 in total

Review 1.  Animal models for the study of arterial hypertension.

Authors:  Waleska C Dornas; Marcelo E Silva
Journal:  J Biosci       Date:  2011-09       Impact factor: 1.826

2.  α-Lipoic acid reduces neurogenic hypertension by blunting oxidative stress-mediated increase in ADAM17.

Authors:  Thyago M de Queiroz; Huijing Xia; Catalin M Filipeanu; Valdir A Braga; Eric Lazartigues
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-08-07       Impact factor: 4.733

3.  Microribonucleic acid-21 increases aldosterone secretion and proliferation in H295R human adrenocortical cells.

Authors:  Damian G Romero; Maria W Plonczynski; Cristian A Carvajal; Elise P Gomez-Sanchez; Celso E Gomez-Sanchez
Journal:  Endocrinology       Date:  2008-01-24       Impact factor: 4.736

4.  Membrane transport in vascular smooth muscle and its relation to normal and altered excitation during hypertension.

Authors:  A W Jones; J M Smith; D B Bylund; E T Garwitz
Journal:  Ann Biomed Eng       Date:  1983       Impact factor: 3.934

Review 5.  Aldosterone and vascular mineralocorticoid receptors: regulators of ion channels beyond the kidney.

Authors:  Jennifer J DuPont; Michael A Hill; Shawn B Bender; Frederic Jaisser; Iris Z Jaffe
Journal:  Hypertension       Date:  2013-12-30       Impact factor: 10.190

6.  Increased microparticle production and impaired microvascular endothelial function in aldosterone-salt-treated rats: protective effects of polyphenols.

Authors:  Natalia López Andrés; Angela Tesse; Véronique Regnault; Huguette Louis; Valérie Cattan; Simon N Thornton; Carlos Labat; Agustine Kakou; Simon Tual-Chalot; Sébastien Faure; Pascale Challande; Mary Osborne-Pellegrin; M Carmen Martínez; Patrick Lacolley; Ramaroson Andriantsitohaina
Journal:  PLoS One       Date:  2012-07-10       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.